Analysis of Single Nucleotide Polymorphisms (SNPs) Rs2234693 and Rs9340799 of the Gene and the Risk of Breast Cancer

Overview

Journal In Vivo

Specialty Oncology

Date 2024 Aug 26

PMID 39187368

Authors

Beata Smolarz

Anna Zadrozna Nowak

Magdalena Brys

Ewa Forma

Honorata Lukasiewicz

Dariusz Samulak

Sara Langner

Hanna Romanowicz

Affiliations

Soon will be listed here.

Abstract

Background/aim: The aim of this study was to analyze rs2234693 and rs9340799 polymorphisms of the ESR1 gene in the context of breast cancer risk in Polish patients.

Materials And Methods: The study involved a group of 117 patients with breast cancer and 106 controls. The analyses were carried out using the polymerase chain reaction - restriction fragments length polymorphism technique.

Results: The presence of the CC genotype in rs2234693 more than doubled the risk of breast cancer (p=0.04), whereas the presence of the TT genotype in rs2234693 significantly reduced the risk of developing this type of cancer (p=0.0002). The presence of the GG genotype in rs9340799 more than doubled the risk of breast cancer (p=0.04), which was confirmed by the analysis of the recessive model (p=0.04).

Conclusion: The polymorphisms rs2234693 and rs9340799 of the ESR1 gene may be associated with the risk of breast cancer among Polish women.

References

Balfe P, McCann A, McGoldrick A, McAllister K, Kennedy M, Dervan P . Estrogen receptor alpha and beta profiling in human breast cancer. Eur J Surg Oncol. 2004; 30(5):469-74. DOI: 10.1016/j.ejso.2004.02.010. View

Zhang Z, Zhang C, Li Y, Zhao Z, Yang S . Association between ERα gene Pvu II polymorphism and breast cancer susceptibility: A meta-analysis. Medicine (Baltimore). 2018; 97(17):e0317. PMC: 5944501. DOI: 10.1097/MD.0000000000010317. View

Tan S, Low T, Hanif E, Sharzehan M, Kord-Varkaneh H, Islam M . The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility. Sci Rep. 2021; 11(1):18619. PMC: 8452701. DOI: 10.1038/s41598-021-97935-8. View

Zhou X, Gu Y, Wang D, Ni S, Yan J . Eight functional polymorphisms in the estrogen receptor 1 gene and endometrial cancer risk: a meta-analysis. PLoS One. 2013; 8(4):e60851. PMC: 3620469. DOI: 10.1371/journal.pone.0060851. View

Gonzalez-Zuloeta Ladd A, Arias Vasquez A, Rivadeneira F, Siemes C, Hofman A, Stricker B . Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat. 2007; 107(3):415-9. PMC: 2217623. DOI: 10.1007/s10549-007-9562-3. View

Su X, Xu X, Li G, Lin B, Cao J, Teng L . ER-α36: a novel biomarker and potential therapeutic target in breast cancer. Onco Targets Ther. 2014; 7:1525-33. PMC: 4155893. DOI: 10.2147/OTT.S65345. View

Kornatska A, Rossokha Z, Fishchuk L, Dubenko O, Medvedieva N, Flaksemberg M . ESR1 gene variants affect FSHR-depended risk of fibrocystic mastopathy in infertile women. Exp Oncol. 2021; 43(3):266-269. DOI: 10.32471/exp-oncology.2312-8852.vol-43-no-3.16468. View

Dai Z, Tian T, Wang M, Yang T, Li H, Lin S . Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women. Cancer Cell Int. 2019; 19:11. PMC: 6325673. DOI: 10.1186/s12935-019-0727-z. View

Jefcoate C, Liehr J, Santen R, Sutter T, Yager J, Yue W . Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr. 2000; (27):95-112. DOI: 10.1093/oxfordjournals.jncimonographs.a024248. View

10.

Onland-Moret N, van Gils C, Roest M, Grobbee D, Peeters P . The estrogen receptor alpha gene and breast cancer risk (The Netherlands). Cancer Causes Control. 2005; 16(10):1195-202. DOI: 10.1007/s10552-005-0307-5. View

11.

Spelsberg T, Rories C, Rejman J, GOLDBERGER A, Fink K, Lau C . Steroid action on gene expression: possible roles of regulatory genes and nuclear acceptor sites. Biol Reprod. 1989; 40(1):54-69. DOI: 10.1095/biolreprod40.1.54. View

12.

Soares Junior J, Mota B, Nobrega G, Filassi J, Sorpreso I, Baracat E . Breast cancer survivals and hormone therapy: estrogen and melatonin. Rev Assoc Med Bras (1992). 2023; 69(10):e6910EDI. PMC: 10547489. DOI: 10.1590/1806-9282.6910EDI. View

13.

Zhu B, Conney A . Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998; 19(1):1-27. DOI: 10.1093/carcin/19.1.1. View

14.

Mohammadi F, Pourahmadi M, Mosalanejad M, Jamali H, Ghobadifar M, Erfanian S . Association of Estrogen Receptor α Genes PvuII and XbaI Polymorphisms with Type 2 Diabetes Mellitus in the Inpatient Population of a Hospital in Southern Iran. Diabetes Metab J. 2013; 37(4):270-7. PMC: 3753492. DOI: 10.4093/dmj.2013.37.4.270. View

15.

Weiderpass E, Persson I, Melhus H, Wedren S, Kindmark A, Baron J . Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis. 2000; 21(4):623-7. DOI: 10.1093/carcin/21.4.623. View

16.

Javed S, Ali M, Sadia S, Aslam M, Masood A, Shaikh R . Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population. Maturitas. 2011; 69(4):377-82. DOI: 10.1016/j.maturitas.2011.05.008. View

17.

Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvanen A . Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res. 2004; 6(4):R437-49. PMC: 468663. DOI: 10.1186/bcr811. View

18.

Key T, Appleby P, Barnes I, Reeves G . Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002; 94(8):606-16. DOI: 10.1093/jnci/94.8.606. View

19.

Carrillo-Moreno D, Figuera L, Zuniga Gonzalez G, Puebla Perez A, Jesus Moran Mendoza A, Arreola M . Association of rs2234693 and rs9340799 polymorphisms of ESR1 gene in breast cancer of Mexican population. J BUON. 2019; 24(5):1927-1933. View

20.

Rahman M, Nakayama K, Rahman M, Ishikawa M, Katagiri H, Katagiri A . ESR1 gene amplification in endometrial carcinomas: a clinicopathological analysis. Anticancer Res. 2013; 33(9):3775-81. View